E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: A novel cardioprotective role

FASEB Journal

Volumn 29, Issue 1, 2015, Pages 61-69

  Aldi, Silvia ^a   Marino, Alice ^a   Tomita, Kengo ^a   Corti, Federico ^a   Anand, Ranjini ^a,b   Olson, Kim E ^a,b   Marcus, Aaron J ^a,b   Levi, Roberto ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Arrhythmias; Atp; P2X7 purinergic receptors; Renin angiotensin system; Toxic aldehydes

Indexed keywords

ACETALDEHYDE; ADENOSINE TRIPHOSPHATE; BETA,GAMMA DIBROMOMETHYLENE 6 N,N DIETHYLADENOSINE TRIPHOSPHATE; CD39 ANTIGEN; ECTO NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; NORADRENALIN; NUCLEOSIDE TRIPHOSPHATE; PHOSPHATASE; PURINERGIC P2X7 RECEPTOR; RAS PROTEIN; RENIN; RNA; UNCLASSIFIED DRUG; 6-N,N-DIETHYL-BETA,GAMMA-DIBROMOMETHYLENE-D-ATP; APYRASE; CARDIOTONIC AGENT; LEUKOCYTE ANTIGEN; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOCRINE EFFECT; BONE MARROW DERIVED MAST CELL; CONTROLLED STUDY; EX VIVO STUDY; GENE OVEREXPRESSION; GENE SILENCING; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MAST CELL; MAST CELL DEGRANULATION; MASTOCYTOMA CELL LINE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN INDUCTION; RENIN RELEASE; REPERFUSION INJURY; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CARDIAC MUSCLE; CELL LINE; CYTOLOGY; DEGRANULATION; DRUG EFFECTS; GENETICS; HEART MUSCLE REPERFUSION; MALE; METABOLISM; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SECRETION (PROCESS);

MURINAE;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIGENS, CD; APYRASE; CARDIOTONIC AGENTS; CELL DEGRANULATION; CELL LINE; HUMANS; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MYOCARDIAL REPERFUSION; MYOCARDIUM; RECEPTORS, PURINERGIC P2X7; RENIN; RENIN-ANGIOTENSIN SYSTEM; RNA, SMALL INTERFERING;

EID: 84937442332     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-261867     Document Type: Article

References (54)

1. Silver, R. B., Reid, A. C., Mackins, C. J., Askwith, T., Schaefer, U., Herzlinger, D., and Levi, R. (2004) Mast cells: a unique source of renin. Proc. Natl. Acad. Sci. USA 101, 13607-13612
2. Mackins, C. J., Kano, S., Seyedi, N., Schäfer, U., Reid, A. C., Machida, T., Silver, R. B., and Levi, R. (2006) Cardiac mast cell-derived renin promotes local angiotensin formation, norepinephrine release, and arrhythmias in ischemia/reperfusion. J. Clin. Invest. 116, 1063-1070
3. Bauer, O., and Razin, E. (2000) Mast cell-nerve interactions. News Physiol. Sci. 15, 213-218
4. Bulanova, E., and Bulfone-Paus, S. (2010) P2 receptor-mediated signaling in mast cell biology. Purinergic Signal. 6, 3-17
5. Kiernan, J. A. (1972) The involvement of mast cells in vasodilatation due to axon reflexes in injured skin. Q. J. Exp. Physiol. Cogn. Med. Sci. 57, 311-317
6. Kiernan, J. A. (1974) Action of adenosine triphosphate on mast cells in normal and denervated skin. Arch. Dermatol. Forsch. 251, 83-86
7. Sesti, C., Koyama, M., Broekman, M. J., Marcus, A. J., and Levi, R. (2003) Ectonucleotidase in sympathetic nerve endings modulates ATP and norepinephrine exocytosis in myocardial ischemia. J. Pharmacol. Exp. Ther. 306, 238-244
8. Knowles, A. F. (2011) The GDA1-CD39 superfamily: NTPDases with diverse functions. Purinergic Signal. 7, 21-45
9. Deaglio, S., and Robson, S. C. (2011) Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity. Adv. Pharmacol. 61, 301-332
10. Kaczmarek, E., Koziak, K., Sévigny, J., Siegel, J. B., Anrather, J., Beaudoin, A. R., Bach, F. H., and Robson, S. C. (1996) Identification and characterization of CD39/vascular ATP diphosphohydrolase. J. Biol. Chem. 271, 33116-33122
11. Marcus, A. J., Broekman, M. J., Drosopoulos, J. H. F., Islam, N., Alyonycheva, T. N., Safier, L. B., Hajjar, K. A., Posnett, D. N., Schoenborn, M. A., Schooley, K. A., Gayle, R. B., and Maliszewski, C. R. (1997) The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J. Clin. Invest. 99, 1351-1360
12. Marcus, A. J., Broekman, M. J., Drosopoulos, J. H., Islam, N., Pinsky, D. J., Sesti, C., and Levi, R. (2003) Heterologous cell-cell interactions: thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1). J. Thromb. Haemost. 1, 2497-2509
13. Jennings, L. K. (2009) Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb. Haemost. 102, 248-257
14. Machida, T., Heerdt, P. M., Reid, A. C., Schaefer, U., Silver, R. B., Broekman, M. J., Marcus, A. J., and Levi, R. (2005) Ectonucleoside triphosphate diphosphohydrolase 1/CD39, localized in neurons of human and porcine heart, modulates ATP-Induced norepinephrine exocytosis. J. Pharmacol. Exp. Ther. 313, 570-577
15. Sesti, C., Broekman, M. J., Drosopoulos, J. H. F., Islam, N., Marcus, A. J., and Levi, R. (2002) EctoNucleotidase in cardiac sympathetic nerve endings modulates ATP-mediated feedback of norepinephrine release. J. Pharmacol. Exp. Ther. 300, 605-611
16. Kurashima, Y., Amiya, T., Nochi, T., Fujisawa, K., Haraguchi, T., Iba, H., Tsutsui, H., Sato, S., Nakajima, S., Iijima, H., Kubo, M., Kunisawa, J., and Kiyono, H. (2012) Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors. Nat. Commun. 3, 1034-1045
17. Koda, K., Salazar-Rodriguez, M., Corti, F., Chan, N. Y.-K., Estephan, R., Silver, R. B., Mochly-Rosen, D., and Levi, R. (2010) Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells. Circulation 122, 771-781
18. Aldi, S., Robador, P. A., Tomita, K., Di Lorenzo, A., and Levi, R. (2014) IgE receptor-mediated mast-cell renin release. Am. J. Pathol. 184, 376-381
19. Aldi, S., Takano, K., Tomita, K., Koda, K., Chan, N. Y., Marino, A., Salazar-Rodriguez, M., Thurmond, R. L., and Levi, R. (2014) Histamine H4-receptors inhibit mast cell renin release in ischemia/reperfusion via protein kinase C ε-dependent aldehyde dehydrogenase type-2 activation. J. Pharmacol. Exp. Ther. 349,508-517
20. Crack, B. E., Pollard, C. E., Beukers, M. W., Roberts, S. M., Hunt, S. F., Ingall, A. H., McKechnie, K. C., IJzerman, A. P., and Leff, P. (1995) Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase. Br. J. Pharmacol. 114, 475-481
21. Honore, P., Donnelly-Roberts, D., Namovic, M. T., Hsieh, G., Zhu, C. Z., Mikusa, J. P., Hernandez, G., Zhong, C., Gauvin, D. M., Chandran, P., Harris, R., Medrano, A. P., Carroll, W., Marsh, K., Sullivan, J. P., Faltynek, C. R., and Jarvis, M. F. (2006) A-740003 [N-(1-[(cyanoimino)(5-quinolinylamino) methyl]amino-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat. J. Pharmacol. Exp. Ther. 319, 1376-1385
22. Corti, F., Olson, K. E., Marcus, A. J., and Levi, R. (2011) The expression level of ecto-NTP diphosphohydrolase1/CD39 modulates exocytotic and ischemic release of neurotransmitters in a cellular model of sympathetic neurons. J. Pharmacol. Exp. Ther. 337, 524-532
23. Donnelly-Roberts, D. L., and Jarvis, M. F. (2007) Discovery of P2X7 receptor-selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states. Br. J. Pharmacol. 151, 571-579
24. Schaefer, U., Machida, T., Broekman, M. J., Marcus, A. J., and Levi, R. (2007) Targeted deletion of ectonucleoside triphosphate diphosphohydrolase 1/CD39 leads to desensitization of pre- and post-synaptic purinergic P2-receptors. J. Pharmacol. Exp. Ther. 322, 1269-1277
25. Maliszewski, C. R., Delespesse, G. J., Schoenborn, M. A., Armitage, R. J., Fanslow, W. C., Nakajima, T., Baker, E., Sutherland, G. R., Poindexter, K., Birks, C., Alpert, A., Friend, D., Gimpel, S. D., and Gayle, R. B., III. (1994) The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J. Immunol. 153, 3574-3583
26. Morrey, C., Brazin, J., Seyedi, N., Corti, F., Silver, R. B., and Levi, R. (2010) Interaction between sensory C-fibers and cardiac mast cells in ischemia/reperfusion: activation of a local renin-angiotensin system culminating in severe arrhythmic dysfunction. J. Pharmacol. Exp. Ther. 335, 76-84
27. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81-128
28. Cordis, G. A., Maulik, N., Bagchi, D., Engelman, R. M., and Das, D. K. (1993) Estimation of the extent of lipid peroxidation in the ischemic and reperfused heart by monitoring lipid metabolic products with the aid of high-performance liquid chromatography. J. Chromatogr. A 632, 97-103
29. Eaton, P., Li, J. M., Hearse, D. J., and Shattock, M. J. (1999) Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart. Am. J. Physiol. 276, H935-H943
30. Steiner, D. R. S., Gonzalez, N. C., and Wood, J. G. (2003) Mast cells mediate the microvascular inflammatory response to systemic hypoxia. J. Appl. Physiol. 94, 325-334
31. Swindle, E. J., and Metcalfe, D. D. (2007) The role of reactive oxygen species and nitric oxide in mast cell-dependent inflammatory processes. Immunol. Rev. 217, 186-205
32. Chen, C.-H., Ferreira, J. C., Gross, E. R., and Mochly-Rosen, D. (2014) Targeting aldehyde dehydrogenase 2: new therapeutic opportunities. Physiol. Rev. 94, 1-34
33. Kuhny, M., Hochdorfer, T., Ayata, C., Idzko, M., and Huber, M. (2014) CD39 is a negative regulator of P2X7-mediated inflammatory cell death in mast cells. Cell Commun. Signal. 12, 40
34. Schömig, A. (1990) Catecholamines in myocardial ischemia. Systemic and cardiac release. Circulation 82 (3 Suppl) II13-II22
35. Meredith, I. T., Broughton, A., Jennings, G. L., and Esler, M. D. (1991) Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N. Engl. J. Med. 325, 618-624
36. Grassi, G., Arenare, F., Pieruzzi, F., Brambilla, G., and Mancia, G. (2009) Sympathetic activation in cardiovascular and renal disease. J. Nephrol. 22, 190-195
37. Tan, A. Y., and Verrier, R. L. (2013) The role of the autonomicnervous system in cardiac arrhythmias. Handb. Clin. Neurol. 117, 135-145
38. Fleetwood, G., Boutinet, S., Meier, M., and Wood, J. M. (1991) Involvement of the renin-angiotensin system in ischemic damage and reperfusion arrhythmias in the isolated perfused rat heart. J. Cardiovasc. Pharmacol. 17, 351-356
39. Harada, K., Komuro, I., Hayashi, D., Sugaya, T., Murakami, K., and Yazaki, Y. (1998) Angiotensin II type 1a receptor is involved in the occurrence of reperfusion arrhythmias. Circulation 97, 315-317
40. 1 receptor blockade in experimental myocardial ischemia/reperfusion. J. Am. Soc. Nephrol. 11 (10 Suppl), S129-S136
41. Yahiro, E., Ideishi, M., Wang, L. X., Urata, H., Kumagai, K., Arakawa, K., and Saku, K. (2003) Reperfusion-induced arrhythmias are suppressed by inhibition of the angiotensin II type 1 receptor. Cardiology 99, 61-67
42. Garg, S., Narula, J., Marelli, C., and Cesario, D. (2006) Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias. Am. J. Cardiol. 97, 921-925
43. Iravanian, S., and Dudley, Jr., S. C. (2008) The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias. Heart Rhythm 5 (6 Suppl) S12-S17
44. von Lewinski, D., Kockskämper, J., Rübertus, S. U., Zhu, D., Schmitto, J. D., Schöndube, F. A., Hasenfuss, G., and Pieske, B. (2008) Direct pro-arrhythmogenic effects of angiotensin II can be suppressed by AT1 receptor blockade in human atrial myocardium. Eur. J. Heart Fail. 10, 1172-1176
45. Calvert, J. A., and Evans, R. J. (2004) Heterogeneity of P2X receptors in sympathetic neurons: contribution of neuronal P2X1 receptors revealed using knockout mice. Mol. Pharmacol. 65, 139-148
46. Reid, A. C., Silver, R. B., and Levi, R. (2007) Renin: at the heart of the mast cell. Immunol. Rev. 217, 123-140
47. Biran, V., Cochois, V., Karroubi, A., Arrang, J. M., Charriaut-Marlangue, C., and Héron, A. (2008) Stroke induces histamine accumulation and mast cell degranulation in the neonatal rat brain. Brain Pathol. 18, 1-9
48. Veerappan, A., Reid, A. C., Estephan, R., O'Connor, N., Thadani-Mulero, M., Salazar-Rodriguez, M., Levi, R., and Silver, R. B. (2008) Mast cell renin and a local renin-angiotensin system in the airway: role in bronchoconstriction. Proc. Natl. Acad. Sci. USA 105, 1315-1320
49. Veerappan, A., Reid, A. C., O'Connor, N., Mora, R., Brazin, J. A., Estephan, R., Kameue, T., Chen, J., Felsen, D., Seshan, S. V., Poppas, D. P., Maack, T., and Silver, R. B. (2012) Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model. Am. J. Physiol. Renal Physiol. 302, F192-F204
50. Kaneko, H., Koshi, S., Hiraoka, T., Miyauchi, Y., Kitamura, N., and Inoue, M. (1998) Inhibition of post-ischemic reperfusion injury of the kidney by diamine oxidase. Biochim. Biophys. Acta 1407, 193-199
51. Vural, K. M., Liao, H., Oz, M. C., and Pinsky, D. J. (2000) Effects of mast cell membrane stabilizing agents in a rat lung ischemia-reperfusion model. Ann. Thorac. Surg. 69, 228-232
52. Walther, T., Olah, L., Harms, C., Maul, B., Bader, M., Hörtnagl, H., Schultheiss, H. P., and Mies, G. (2002) Ischemic injury in experimental stroke depends on angiotensin II. FASEB J. 16, 169-176
53. Guo, L., Richardson, K. S., Tucker, L. M., Doll, M. A., Hein, D. W., and Arteel, G. E. (2004) Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats. Hepatology 40, 583-589
54. Chen, S., Li, G., Zhang, W., Wang, J., Sigmund, C. D., Olson, J. E., and Chen, Y. (2009) Ischemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 297, R1526-R1531